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Di-anionic self-associating supramolecular
amphiphiles (SSAs) as antimicrobial agents against
MRSA and Escherichia coli†
Lisa J. White,a Jessica E. Boles,ab Melanie Clifford,c Bethany L. Patenall,c
Kira H. L. F. Hilton,a Kendrick K. L. Ng,a Rebecca J. Ellaby,a Charlotte K. Hind,*c
Daniel P. Mulvihill*b and Jennifer R. Hiscock *a
Herein, we report a series of di-anionic supramolecular self-associating
amphiphiles (SSAs). We elucidate the antimicrobial properties of these
SSAs against both methicillin resistant Staphylococcus aureus and
Escherichia coli. In addition, we show this class of compound to form
both intra- and intermolecular hydrogen bonded macrocyclic struc-
tures in the solid state.
Antimicrobial resistance (AMR) is a growing threat to public
health worldwide.1 The misuse of antibiotics/antimicrobial
agents within the veterinarian2 and clinical3 sectors has con-
tributed to the emergence of multi-drug-resistant organisms,
some of which are resistant to all antimicrobial agents currently
marketed.4 As a result, it has been predicted that by the year
2050 the number of global deaths attributed to the primary
effects of AMR will be greater than those caused by cancer
(2014), decreasing the worlds GDP by $100 trillion.5
Supramolecular chemistry has long utilised macrocyclic struc-
tures to enable selective host:guest complex formation.6–8 Over time
these structures have been incorporated into ever more com-
plex systems, which includes but is not limited to; rotaxanes,9
catenanes10 and biologically inspired molecular machines.11–13
While the development of antimicrobial amphiphiles could be
considered well known,14–16 the exploration of traditional supra-
molecular macrocyclic scaffolds for the development of novel
antimicrobial agents has been of interest since the 1950s, initiated
by Macrocyclon.17 Naturally occurring peptide based rotaxanes
have also been shown to elicit specific bioactivities.18,19 For
example, microcin J25 acts as an RNA polymerase inhibiter,20 a
property causing it to be targeted as a potential antimicrobial
therapy.21 Furthermore, He and co-workers have developed a
complex pillar[5]arene which has been shown to effectively carry,
deliver and release the antibiotic vancomycin into methicillin
resistant Staphylococcus aureus (MRSA), enhancing the intracellu-
lar concentration of the antibiotic and thus enhancing efficacy.22
Our work in this field to date has led to the identification of
a novel class of supramolecular self-associating amphiphiles
(SSAs)23,24 as: selective phospholipid membrane co-ordination
agents,25,26 antimicrobial agents against Gram-negative Escher-
ichia coli (E. coli) and Gram-positive MRSA,27–29 anticancer
agents,30 potential drug delivery vehicles,31 and therapeutic
efficacy enhancement agents.30,32 Here, we present a series of
three next-generation di-anionic SSAs (1, 3, 4 – Fig. 1), and
report the self-associative properties of these amphiphilic salts
Fig. 1 Chemical structures of di-anionic SSAs (1, 3 and 4), mono-anionic
SSA 5 and synthetic intermediate (2). TBA = tetrabutylammonium.
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in the solid state and in aqueous solutions, before exploring the
potential of these compounds as antimicrobial agents against
both E. coli and clinically relevant MRSA.
SSA 1 was obtained through the addition of tetrabutylammo-
nium (TBA) aminomethanesulfonate (AMS) to 4,40-methyle-
nebis(phenyl isocyanate) and isolated as a cream solid in a yield
of 80%. SSA 3 was obtained through the reduction of intermediate 2,
to produce the corresponding amine, which was then reacted with
triphosgene to give the corresponding bisisocyanate. This bisisocya-
nate was then reacted with TBA AMS, to give 3, which was obtained
as a yellow solid in a yield of 59%. SSA 4 was obtained through the
addition of TBA AMS to 1,30-bis(1-isocyanato-1-methyl-ethyl) ben-
zene and isolated as a colourless oil in a yield of 67%. The synthesis
of SSA 5 has previously been reported.33
As observed with the majority of TBA containing mono-
anionic SSAs,28 in the solid state, single-crystal X-ray diffraction
studies confirmed the self-association of di-anionic SSAs 1 and
4 through the formation of sulfonate-urea hydrogen bonds.
Interestingly, the self-association of 1 resulted in the formation
of the rectangular macrocycle shown in Fig. 2. Here the
formation of 8 intermolecular hydrogen bonds stabilise the
formation of this anionic dimer, with two of the four TBA
counter cations threading themselves through the anionic
macrocycles cavity.
In contrast to 1, the anionic component of 4 (Fig. 3) self-
associates through the formation of intra-rather than intermo-
lecular sulfonate-anion hydrogen bonds. Although these self-
associative events still result in macrocycle formation, in this
instance an anionic, monomeric helical macrocycle is formed,
stabilised through the formation of four rather than 8 urea-
anion hydrogen bonds.
Moving into the solution state, the presence of any SSA
hydrogen bonded self-association events were initially verified
through a combination of quantitative 1H NMR, 1H NMR DOSY
and 1H NMR dilution studies in a DMSO-d6 solution. This is in
line with our previous work.23,24,31 However, as these data are
not the main focus of the work presented here, these data are
presented within the ESI† only.
The self-associative properties of SSAs 1 and 3–5 were
explored in a D2O/EtOH 95 : 5 or H2O/EtOH 95 : 5 solution, to
aid SSA solubility and enable comparison with previously
published SSA data.23,24,28 Quantitative 1H NMR studies con-
firmed the presence of aggregated species with solid-like prop-
erties at 5.56 mM for all SSAs. The physical properties of these
aggregates were elucidated through a combination of dynamic
light scattering (DLS), zeta potential and tensiometry (enabling
the determination of critical micelle concentration – CMC
values) studies (Table 1).
Quantitative 1H NMR studies enable the estimation of the
proportion of an SSA apparently ‘lost’ from solution, through
the adoption of solid-like properties as a result of higher order
self-association events, causing this proportion of molecular
species to become NMR silent. Here comparative integration of
those signals from the SSA anion or cation against an internal
standard (EtOH) allows for the percentage of a molecular
component apparently ‘lost’ from solution to be calculated.
When compared to mono-anionic SSA 5, the proportion of
di-anionic SSA 1 to become NMR silent under analogous experi-
mental conditions remains comparable. However, this is not the
case for 3 and 4, where not only does the proportion of the SSA to
be incorporated into these aggregated structures change, but also
the ratios of SSA anion:cation. Here, a 2.10 : 1.00 and 1.39 : 1.00
anion:cation ratio is observed for those higher order aggregated
structures of 3 and 4 respectively. We hypothesise that in this
instance, this is due to partial protonation/deuteration of the
SSA’s anionic substituent, resulting from solution state aggrega-
tion processes. However, this phenomenon remains the subject of
ongoing investigations.
The hydrodynamic diameter (dH), of those self-associated
aggregates produced by SSAs 1, 3, 4 and 5 in a H2O/EtOH 95 : 5
solution at 5.56 mM were obtained from DLS studies after
undergoing an annealing process ESI.† The stability of those
aggregates present within those same solutions was obtained
through complimentary zeta potential measurements. The dH
of the aggregates formed by di-anionic SSAs 1, 3 and 4 was
found to vary, with 1 exhibiting aggregates with the most
Fig. 2 Single-crystal X-ray structure of 1 (Fig. S46 and Table S6, ESI†),
showing the formation of an intermolecular hydrogen bonded macrocycle
illustrated as both (a) a ball and stick (grey = carbon, blue = nitrogen,
red = oxygen, yellow = sulfur, white = hydrogen, red dashed lines =
hydrogen bonds) and, (b) a space filling model (Black = hydrogen bonded,
macrocyclic anionic dimer; Green = TBA counter cation). Two of the four
TBA counter cations associated with this complex have been omitted for
clarity.
Fig. 3 Single-crystal X-ray structure of 4 (Fig. S47 and Table S7, ESI†),
showing the formation of an anionic, helical macrocycle, stabilised
through the formation of four hydrogen bonds. TBA counter cations and
associated water molecules have been omitted for clarity. Grey = carbon,
blue = nitrogen, red = oxygen, yellow = sulfur, white = hydrogen, red
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comparable in size distribution profile to mono-anionic SSA 5.
We hypothesise that this may be due to the increased structural
rigidity of 1 in comparison to 3 and 4, causing di-anionic SSA 1
to adopt aggregate properties that are comparable to mono-
anionic SSAs. The enhanced flexibility of 3, afforded through
the addition of the central propyl group, combined with the
addition of lipophilic, electron withdrawing CF3 substituents,
although decreased SSA aggregate uniformity, was found to
improve/maintain aggregate stability when compared to 1 and
5 respectively. However, both aggregate uniformity and stability
was decreased with 4, conceivably due to competitive intra-
molecular hydrogen bond formation events.
When ranking this group of SSAs according to CMC value,
we observe the following: 4 4 1 4 5 4 3 (Table 1). Here, in line
with previous observations,28 SSA anion lipophobicity and
intermolecular hydrogen-bond formation events are hypothe-
sised to influence critical micelle concentration (CMC) values.
With the addition of the CF3 and propyl linker groups found to
lower the CMC of di-anionic SSA 3 below that obtained for
mono-anionic SSA 5.
Within the scope of our antimicrobial efficacy studies, the
SSA is added to the microbial culture in a H2O/EtOH 95 : 5
solution. This ensures that the SSA antimicrobial effects can be
directly related to those SSA aggregates characterised in
Table 1. We have previously shown mono-anionic SSAs to
interact with, and permeate bacterial membranes.25,28,30,32
The results summarised in Table 2 show the di-anionic SSAs
have an enhanced antimicrobial selectivity for Gram +ve MRSA
over Gram ve E. coli and a low cytotoxicity profile against
human red blood cells. Interestingly, when ranking the %
haemolysis induced by 1, 3–5, this was found to differ from
the ranking of antimicrobial activity. Furthermore, di-anionic
SSA 4 was found to exhibit a% haemolysis 9 times less than the
mono-anionic SSA 5. These observations act as evidence
towards the hypothesis that SSA technology can be tailored
with bespoke activity towards different cell lines, thus enabling
the control of unwanted toxic effects, and highlighting the
potential for this technology for further development into the
clinic.
The antimicrobial efficacy of di-anionic SSAs 1, 3 and 4 was
found to decrease with increasing % of the SSAs anionic
component to be incorporated into solid-like aggregated struc-
tures (Table 1 – quantitative 1H NMR). This causes us to
hypothesise that the di-anionic SSA mode of action maybe
dependent on a critical concentration of SSA to arrive at the
microbial surface in an aggregated form before an antimicro-
bial effect can be achieved,24,27,28,32 in an analogous fashion to
that described by the antimicrobial carpet mechanism.34 How-
ever, it is also conceivable that the flexibility and lipophobicity
of the di-anion central linker may be a contributing factor to aid
membrane permeation, through effective shielding of the SSA
anions charged functionalities.
In conclusion, we report a series of next-generation, di-
anionic SSAs and characterise the self-associative properties
of these amphiphilic salts within the solution state ESI† and
solid state. We show how intra- or intermolecular SSA di-anion
hydrogen bond formation maybe used to produce new classes
of self-associated macrocycles, highlighting the potential of
this structural motif to be developed as foldamers, rotaxanes
or catenanes. In addition, we report the enhanced antimicro-
bial selectivity of di-anionic SSAs for clinically relevant Gram
+ve MRSA over Gram ve E. coli and show these agents to
exhibit low toxicity towards human red blood cells. It is the
combination of these data that highlights the potential of this
technology to not only be developed into the clinical space, but
also for the production of novel classes of complex, self-
assembled supramolecular systems. As a result of these find-
ings we now aim to focus our work to derive the mechanism of
antimicrobial action for this class of agents.
L. White: investigation; validation; writing – original draft.
J. Boles, B. Patenall and M. Clifford: investigation; writing –
original draft. K. Hilton, K. Ng and R. Ellaby: investigation.
C. Hind and D. Mulvihill: funding acquisition; validation;
Table 1 Physicochemical data produced to characterise SSA self-association events in a H2O/EtOH 95 : 5 or D2O/EtOH 95 : 5 (NMR only) solution.
Aggregate stability and dH were obtained via zeta potential and DLS measurements respectively, at a concentration of 5.56 mM and a temperature of
298 K, following an annealing process. The dH of the aggregates listed were obtained from intensity distribution peak maxima. CMC was derived at
approximately 291 K from surface tension measurements.38 All quantitative 1H NMR experiments were conducted with a delay time (d1) of 60 s at 298 K
and a concentration of 5.56 mM. The values given in % represent the observed proportion of compound to become NMR silent
SSA
Quantitative 1H NMR (%)a
dH (nm) Zeta potential (mV) CMC (mM) Surface tension at CMC (mN m
1)anion cation
1 45 52 117 67 24.22 49.31
3 82 39 12, 82, 5412 74 5.77 40.76
4 68 49 1, 214, 2950 11 58.59 45.43
528 51 50 164 76 10.39 37.45
a Quantitative 1H NMR studies were performed using EtOH as the internal standard.
Table 2 MIC50 values (mM) determined for 1, 3, 4 and 5 against clinically
relevant Gram +ve MRSA USA300 and Gram ve E. coli DH10B at an initial
calibrated cell concentration equal to the 0.5 McFarland standard, after
900 mins. The cytotoxicity of the SSAs was measured by haemolysis of
human red blood cells at 2 mM of SSA.35 Error = standard deviation to 2 dp
SSA MRSA E.coli % Haemolysis
1 1.29  0.15 a 8.2  3.66
3 0.44  0.04 a 13.0  0.44
4 0.91  0.04 22.5  0.02 0.7  0.09
532 0.46  0.03 3.85  0.07 6.3  2.23
a SSA did not pass initial antimicrobial screening, exhibited o 10%
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